Showing results (151-160 of 170) with videos related to
Sort By:
Pageof 17
Diabetologia|August 23, 2024
Comparative renal outcomes of matched cohorts of patients with type 2 diabetes receiving SGLT2 inhibitors or GLP-1 receptor agonists under routine careGian Paolo Fadini, Enrico Longato, Mario Luca Morieri, et al.Arthritis Research & Therapy|October 8, 2015
Early treatment with hydroxychloroquine prevents the development of endothelial dysfunction in a murine model of systemic lupus erythematosusAgostino Virdis, Chiara Tani, Emiliano Duranti, et al.BMC Medicine|April 27, 2019
Is resistant hypertension an independent predictor of all-cause mortality in individuals with type 2 diabetes? A prospective cohort studyAnna Solini, Giuseppe Penno, Emanuela Orsi, et al.Arteriosclerosis, Thrombosis, and Vascular Biology|September 10, 2005
Selective insulin resistance affecting nitric oxide release but not plasminogen activator inhibitor-1 synthesis in fibroblasts from insulin-resistant individualsAssunta Pandolfi, Anna Solini, Giuliana Pellegrini, et al.Diabetes|July 8, 2009
TIMP3 is reduced in atherosclerotic plaques from subjects with type 2 diabetes and increased by SirT1Marina Cardellini, Rossella Menghini, Eugenio Martelli, et al.Diabetes Research and Clinical Practice|August 29, 2018
A renal genetic risk score (GRS) is associated with kidney dysfunction in people with type 2 diabetesChiara Zusi, Maddalena Trombetta, Sara Bonetti, et al.Atherosclerosis|May 27, 2011
The Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) equation provides a better definition of cardiovascular burden associated with CKD than the Modification of Diet in Renal Disease (MDRD) Study formula in subjects with type 2 diabetesGiuseppe Pugliese, Anna Solini, Enzo Bonora, et al.Acta Diabetologica|June 3, 2024
GLP1-GIP receptor co-agonists: a promising evolution in the treatment of type 2 diabetesStefano Ciardullo, Mario Luca Morieri, Giuseppe Daniele, et al.European Heart Journal|May 25, 2011
Resistance artery mechanics and composition in angiotensin II-infused mice: effects of cyclooxygenase-1 inhibitionAgostino Virdis, Rocchina Colucci, Mario Fritsch Neves, et al.European Journal of Preventive Cardiology|September 26, 2024
Circadian heart rate fluctuations predict cardiovascular and all-cause mortality in type 2 and type 1 diabetes: a 21-year retrospective longitudinal studyLorenzo Nesti, Martina Chiriacò, Luca Sacchetta, et al.Pageof 17